super herohasbro

HASBRO AND SUPER HEROIC TEAM UP TO PROMOTE ACTIVE PLAY

WITH NEW NERF APPAREL AND FOOTWEAR LINE

 

New Licensing Agreement Brings NERF-Branded Gender-Neutral Kids Clothing and Shoes to the US in July

 

PAWTUCKET, R.I.– July 31,2019 –Super Heroic, Inc. a tactical play company, and HASBRO, Inc. (NASDAQ:HAS), a global play and entertainment company, announced today a licensing agreement to bring NERF-branded kids’ apparel and footwear to market this August . The line will be available at Foot Locker and Kids Foot Locker, select Foot Locker and Kids Foot Locker stores, and online at Super Heroic, Inc.,www.footlocker.com, and www.kidsfootlocker.com

Designed for active play, the NERF x Super Heroic collection consists of an update to its lead footwear. The TMBLR v2 will launch with two new colors, and the collection will also introduce a brand-new silhouette titled the JMPR v2 in two colors featuring a new alternative closure with elastic laces and a toggle system. These exciting footwear styles are rounded out by an apparel collection featuring gender-neutral tops, joggers, and t-shirts. The products will feature collaborative branding, plus individual pockets and compartments designed to hold NERF products.

“Our collaboration with Super Heroic is driven by our common mission to promote active play,” said Casey Collins, GM & SVP Entertainment and Licensing, Hasbro. “Together we want to encourage kids to play hard, explore and get dirty.  We’re excited to launch this collection just in time for kids to head back to school.”

“The power of this collaboration rests solely in the alignment of our shared values and the importance of our collective missions,” said Jason Mayden, CEO & Co-Founder, Super Heroic. “As a child of the 90’s, Nerf represents the apex of immersive, active play. It represents the freedom and wonderment of childhood that imbues us all with a sense of unrestricted creativity and limitless potential. We are honored and excited to partner with Nerf to launch a collection that reminds us all, that if we can play together, we can live together.”


 

About Hasbro

Hasbro (NASDAQ: HAS) is a global play and entertainment company committed to Creating the World's Best Play Experiences. From toys and games to television, movies, digital gaming and consumer products, Hasbro offers a variety of ways for audiences to experience its iconic brands, including NERF, MY LITTLE PONY, TRANSFORMERS, PLAY-DOH, MONOPOLY, BABY ALIVE,MAGIC: THE GATHERING and POWER RANGERS as well as premier partner brands. Through its entertainment labels, Allspark Pictures and Allspark Animation, the Company is building its brands globally through great storytelling and content on all screens. Hasbro is committed to making the world a better place for children and their families through corporate social responsibility and philanthropy. Hasbro ranked No. 13 on the 2019 100 Best Corporate Citizens list by CR Magazine, and has been named one of the World’s Most Ethical Companies® by Ethisphere Institute for the past eight years. Learn more at www.hasbro.com, and follow us on Twitter (@Hasbro) and Instagram (@Hasbro).

 

About Super Heroic

Super Heroic is an award winning, tactical play company based in Oakland, CA whose mission is to entertain, delight and surprise every child in the world through imaginative and interactive play. This lifestyle brand provides youth with a new uniform of play, starting with footwear and apparel using technical and high performance design creating a line targeted explicitly for children.

newswirelogo

  • SHANGHAI, China, Aug. 07, 2020 (GLOBE NEWSWIRE) -- Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Greater China and other parts of Asia, today announced that the first patient has been dosed in a Phase 1b/2 study evaluating FGF401 in combination with PD-1 inhibitor, pembrolizumab, in patients with advanced solid tumors, such as hepatocellular carcinoma (HCC).

  • 中国上海, Aug. 07, 2020 (GLOBE NEWSWIRE) -- 云顶新耀(Everest Medicines),一家专注于创新药开发及商业化的生物制药公司,致力于满足大中华区及其它亚洲市场未被满足的医疗需求,今日宣布在FGF401联合PD-1抑制剂Pembrolizumab用于治疗晚期实体瘤(例如肝细胞癌)的1b/2期临床研究中完成首例受试者给药。

  • HOUSTON, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Houston Wire & Cable Company (NASDAQ: HWCC) (the “Company”) announced operating results for the second quarter ended June 30, 2020 and progress on its cost and debt reduction programs.

  • CAMBRIDGE, Mass., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI), a clinical stage biotechnology company focused on developing proprietary technology to harness the power of the immune system to combat cancer, today announced the pricing of its initial public offering of 5,000,000 shares of common stock at a public offering price of $15.00 per share. All of the shares are being offered by Checkmate. Checkmate’s common stock is expected to begin trading on the Nasdaq Global Market under the ticker symbol “CMPI” on August 7, 2020. The gross proceeds of the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Checkmate, are expected to be approximately $75,000,000. The offering is expected to close on August 11, 2020, subject to the satisfaction of customary closing conditions. Checkmate has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares of common stock at the initial public offering price, less the underwriting discounts and commissions.

  • AUSTIN, Texas, Aug. 06, 2020 (GLOBE NEWSWIRE) -- ESW Capital, LLC (“ESW”) – confirms that it has delivered today an application to the Ontario Securities Commission (the “OSC”) for an exemption from the “majority of the minority” requirement contained in Section 2.29.1(c) of National Instrument 62-104 (the “Exemption”) in connection with its previously announced intention to make an offer to acquire any and all subordinate voting shares (the “Shares”) in the capital of Optiva, Inc. (TSX:OPT) (“Optiva”) at the price of CAD $60 per Share (the “Offer”).

Contact Us

Retail Merchandiser Magazine

Cringleford Business Centre,
Intwood Road Cringleford,
Norwich, UK, NR6 4AU

  +44 (0) 1603 274 130

Click here for a full list of contacts.

Back To Top